<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2022-03-11T00:54:24Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8103671" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8103671</identifier>
        <datestamp>2021-05-10</datestamp>
        <setSpec>idp</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Infect Dis Poverty</journal-id>
              <journal-id journal-id-type="iso-abbrev">Infect Dis Poverty</journal-id>
              <journal-title-group>
                <journal-title>Infectious Diseases of Poverty</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">2095-5162</issn>
              <issn pub-type="epub">2049-9957</issn>
              <publisher>
                <publisher-name>BioMed Central</publisher-name>
                <publisher-loc>London</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8103671</article-id>
              <article-id pub-id-type="pmcid">PMC8103671</article-id>
              <article-id pub-id-type="pmc-uid">8103671</article-id>
              <article-id pub-id-type="pmid">33962683</article-id>
              <article-id pub-id-type="publisher-id">843</article-id>
              <article-id pub-id-type="doi">10.1186/s40249-021-00843-2</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Short Report</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Coronavirus disease 2019 outbreak in Beijing’s Xinfadi Market, China: a modeling study to inform future resurgence response</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author" equal-contrib="yes">
                  <name>
                    <surname>Wang</surname>
                    <given-names>Xiao-Li</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <contrib contrib-type="author" equal-contrib="yes">
                  <name>
                    <surname>Lin</surname>
                    <given-names>Xin</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author" equal-contrib="yes">
                  <name>
                    <surname>Yang</surname>
                    <given-names>Peng</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wu</surname>
                    <given-names>Zun-You</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Li</surname>
                    <given-names>Gang</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>McGoogan</surname>
                    <given-names>Jennifer M.</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff5">5</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Jiao</surname>
                    <given-names>Zeng-Tao</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>He</surname>
                    <given-names>Xin-Jun</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff6">6</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Li</surname>
                    <given-names>Si-Qi</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff7">7</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Shi</surname>
                    <given-names>Hong-Hao</given-names>
                  </name>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Wang</surname>
                    <given-names>Jing-Yuan</given-names>
                  </name>
                  <address>
                    <email>jywang@buaa.edu.cn</email>
                  </address>
                  <xref ref-type="aff" rid="Aff4">4</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Lai</surname>
                    <given-names>Sheng-Jie</given-names>
                  </name>
                  <address>
                    <email>shengjie.lai@soton.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="Aff8">8</xref>
                  <xref ref-type="aff" rid="Aff9">9</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Huang</surname>
                    <given-names>Chun</given-names>
                  </name>
                  <address>
                    <email>huangch@bjcdc.on.ac.uk</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9552-2503</contrib-id>
                  <name>
                    <surname>Wang</surname>
                    <given-names>Quan-Yi</given-names>
                  </name>
                  <address>
                    <email>bjcdcxm@126.com</email>
                  </address>
                  <xref ref-type="aff" rid="Aff1">1</xref>
                  <xref ref-type="aff" rid="Aff3">3</xref>
                </contrib>
                <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.418263.a</institution-id><institution>Beijing Research Center for Preventive Medicine, </institution><institution>Beijing Center for Disease Prevention and Control, </institution></institution-wrap>Beijing, China </aff>
                <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.24696.3f</institution-id><institution-id institution-id-type="ISNI">0000 0004 0369 153X</institution-id><institution>School of Public Health, </institution><institution>Capital Medical University, </institution></institution-wrap>Beijing, China </aff>
                <aff id="Aff3"><label>3</label>Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing, China </aff>
                <aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.64939.31</institution-id><institution-id institution-id-type="ISNI">0000 0000 9999 1211</institution-id><institution>School of Computer Science and Engineering, </institution><institution>Beihang University, </institution></institution-wrap>Beijing, China </aff>
                <aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.198530.6</institution-id><institution-id institution-id-type="ISNI">0000 0000 8803 2373</institution-id><institution>Chinese Center for Disease Control and Prevention, </institution></institution-wrap>Beijing, China </aff>
                <aff id="Aff6"><label>6</label>Yidu Cloud AI Lab, Yidu Cloud (Beijing) Technology Co., Ltd, Beijing, China </aff>
                <aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="GRID">grid.21107.35</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9311</institution-id><institution>Johns Hopkins Bloomberg School of Public Health, </institution><institution>Johns Hopkins University, </institution></institution-wrap>Baltimore, MD USA </aff>
                <aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="GRID">grid.5491.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9297</institution-id><institution>WorldPop, School of Geography and Environmental Science, </institution><institution>University of Southampton, </institution></institution-wrap>Southampton, UK </aff>
                <aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="GRID">grid.8547.e</institution-id><institution-id institution-id-type="ISNI">0000 0001 0125 2443</institution-id><institution>School of Public Health, Key Laboratory of Public Health Safety, Ministry of Education, </institution><institution>Fudan University, </institution></institution-wrap>Shanghai, China </aff>
              </contrib-group>
              <pub-date pub-type="epub">
                <day>7</day>
                <month>5</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>7</day>
                <month>5</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2021</year>
              </pub-date>
              <volume>10</volume>
              <elocation-id>62</elocation-id>
              <history>
                <date date-type="received">
                  <day>26</day>
                  <month>1</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>14</day>
                  <month>4</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© The Author(s) 2021</copyright-statement>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
                </license>
              </permissions>
              <abstract id="Abs1">
                <sec>
                  <title>Background</title>
                  <p id="Par1">A local coronavirus disease 2019 (COVID-19) case confirmed on June 11, 2020 triggered an outbreak in Beijing, China after 56 consecutive days without a newly confirmed case. Non-pharmaceutical interventions (NPIs) were used to contain the source in Xinfadi (XFD) market. To rapidly control the outbreak, both traditional and newly introduced NPIs including large-scale management of high-risk populations and expanded severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) PCR-based screening in the general population were conducted in Beijing. We aimed to assess the effectiveness of the response to the COVID-19 outbreak in Beijing’s XFD market and inform future response efforts of resurgence across regions.</p>
                </sec>
                <sec>
                  <title>Methods</title>
                  <p id="Par2">A modified susceptible–exposed–infectious–recovered (SEIR) model was developed and applied to evaluate a range of different scenarios from the public health perspective. Two outcomes were measured: magnitude of transmission (i.e., number of cases in the outbreak) and endpoint of transmission (i.e., date of containment). The outcomes of scenario evaluations were presented relative to the reality case (i.e., 368 cases in 34 days) with 95% Confidence Interval (CI).</p>
                </sec>
                <sec>
                  <title>Results</title>
                  <p id="Par3">Our results indicated that a 3 to 14 day delay in the identification of XFD as the infection source and initiation of NPIs would have caused a 3 to 28-fold increase in total case number (31–77 day delay in containment). A failure to implement the quarantine scheme employed in the XFD outbreak for defined key population would have caused a fivefold greater number of cases (73 day delay in containment). Similarly, failure to implement the quarantine plan executed in the XFD outbreak for close contacts would have caused twofold greater transmission (44 day delay in containment). Finally, failure to implement expanded nucleic acid screening in the general population would have yielded 1.6-fold greater transmission and a 32 day delay to containment.</p>
                </sec>
                <sec>
                  <title>Conclusions</title>
                  <p id="Par4">This study informs new evidence that in form the selection of NPI to use as countermeasures in response to a COVID-19 outbreak and optimal timing of their implementation. The evidence provided by this study should inform responses to future outbreaks of COVID-19 and future infectious disease outbreak preparedness efforts in China and elsewhere.</p>
                </sec>
                <sec>
                  <title>Graphical abstract</title>
                  <p id="Par100">
                    <graphic position="anchor" xlink:href="40249_2021_843_Figa_HTML" id="MO6"/>
                  </p>
                </sec>
                <sec>
                  <title>Supplementary Information</title>
                  <p>The online version contains supplementary material available at 10.1186/s40249-021-00843-2.</p>
                </sec>
              </abstract>
              <kwd-group xml:lang="en">
                <title>Keywords</title>
                <kwd>Public health</kwd>
                <kwd>Nonpharmaceutical intervention</kwd>
                <kwd>COVID-19</kwd>
                <kwd>SARS-CoV-2</kwd>
                <kwd>Beijing</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100012401</institution-id>
                      <institution>Beijing Science and Technology Planning Project</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>Z201100005420010</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Yang</surname>
                      <given-names>Peng</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution>National Key R&amp;D Program of China</institution>
                  </funding-source>
                  <award-id>2019YFB2102103</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Jing-Yuan</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <funding-group>
                <award-group>
                  <funding-source>
                    <institution>National Natural Science Foundation of China </institution>
                  </funding-source>
                  <award-id>92046010</award-id>
                  <award-id>82161148011</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Jing-Yuan</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>issue-copyright-statement</meta-name>
                  <meta-value>© The Author(s) 2021</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec id="Sec1">
              <title>Background</title>
              <p id="Par15">Although it has been more than 12 months since the first confirmed case of novel coronavirus disease 2019 (COVID-19) was reported, and vaccines have been approved and rolled out in some countries to protect high-risk populations for severe outcomes, for the time being non-pharmaceutical interventions (NPIs) remain primary public health measures to slow the transmission and reduce the healthcare burden before vaccines are widely available and herd immunity can be achieved. Since the early stage of the pandemic, there have been a series of studies to understand the impacts of response policymaking and NPIs implementation on COVID-19, using mathematical modeling and simulations [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR3">3</xref>]. Different NPIs such as case isolation, close contact tracing and quarantine, social distancing, mask wearing, and travel restrictions have a varying effectiveness in controlling the transmission of COVID-19 across regions and time [<xref ref-type="bibr" rid="CR4">4</xref>–<xref ref-type="bibr" rid="CR10">10</xref>]. However, few studies investigated the resurgences of COVID-19 transmission and it is little known about the effectiveness of NPIs for controlling secondary waves in regions where the COVID-19 epidemic has been contained [<xref ref-type="bibr" rid="CR11">11</xref>].</p>
              <p id="Par16">The COVID-19 outbreak in Beijing’s Xinfadi (XFD) Wholesale market occurred on June 11, 2020 after 56 consecutive days without a newly confirmed case in Beijing. The resurgence was brought under control in just 34 days from the onset of illness of the first known case (June 5, 2020) to zero new infections detected (July 10, 2020) [<xref ref-type="bibr" rid="CR11">11</xref>]. It offers an exceptional opportunity to develop a model using real-world data and to quantitatively evaluate the timing and impact of integrated NPIs for containing COVID-19 resurgences. The source of this outbreak was identified as the virus spread from XFD market [<xref ref-type="bibr" rid="CR12">12</xref>], the largest wholesale food market in Asia that has about 3000 workers and 50 000 visitors each day and provides about 80% of Beijing’s food supply. Within the massive XFD market complex, there are a total of 14 trading halls. One of which, the Beef and Mutton Trading Hall (BMTH), has been identified as the major infection source in this outbreak [<xref ref-type="bibr" rid="CR12">12</xref>]. After the new outbreak was discovered on June 11, the municipal government have adopted a two-pronged approach—re-instating NPIs used during the initial wave in January–March 2020 and introducing new NPIs including: (i) large-scale tracing and management of high-risk populations identified by exposure risk levels, and (ii) expanded SARS-CoV-2 nucleic acid screening in the general population in Beijing.</p>
              <p id="Par17">The implementation of combining interventions have rapidly and successfully contained the resurgence and interrupted the transmission, and only 362 confirmed cases, 40 asymptomatic infections in Beijing and 34 linked infections outside Beijing were found, with zero deaths and less disruption to routine socioeconomic activities [<xref ref-type="bibr" rid="CR11">11</xref>]. To assess the effectiveness of the response to the COVID-19 outbreak in Beijing’s XFD market and inform future response efforts of resurgence across regions, we developed a COVID-19 outbreak modeling framework to examine impacts of various identification timings and NPIs for this outbreak under hypothetical response scenarios.</p>
            </sec>
            <sec id="Sec2">
              <title>Methods</title>
              <sec id="Sec3">
                <title>Study design</title>
                <p id="Par18">We constructed a modified susceptible–exposed–infectious–recovered (SEIR) model to evaluate the effectiveness of NPIs in containing COVID-19 after the outbreak in Beijing’s XFD market. We specifically modeled four scenarios for two key outcomes: the magnitude of transmission and the endpoint of transmission. Our methods and results were reported according to guidelines developed by Bennett and Manuel [<xref ref-type="bibr" rid="CR13">13</xref>]. Ethical approval and informed consent requirements were waived by the Institutional Review Board and Human Research Ethics Committee of the Beijing Center for Disease Prevention and Control (Beijing CDC) because this study was considered a continuation of the public health investigation associated with an emerging infectious disease.</p>
              </sec>
              <sec id="Sec4">
                <title>Data source</title>
                <p id="Par19">The details of the Beijing XFD market outbreak and NPIs implemented in response, have been previously described [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. The data used in this study were extracted from the Notifiable Infectious Disease Reporting System (basic individual case-level demographics, location, and diagnostic data), the Epidemiological Investigation Information System (detailed individual case-level exposure, symptom, and clinical data), and the Close Contacts Tracing and Management System (individual contact-level demographics, exposures, location, and quarantine data) [<xref ref-type="bibr" rid="CR14">14</xref>]. A summary of Beijing XFD outbreak data used in developing the model is presented in Table <xref rid="Tab2" ref-type="table">2</xref>.</p>
                <p id="Par20">The epidemiologic parameters such as incubation periods and contagious periods were calculated based on data from the epidemiological investigation and close contacts tracing and management. For incubation periods, we extracted 41 individual laboratory-confirmed records that have known dates of exposure. By combing the date of exposure with the date of symptom onset, we inferred the incubation periods for the 41 individual cases. We fitted the distribution of incubation periods to a Weibull distribution using a Maximum Likelihood Estimation method with R package <italic>fitdistrplus</italic> (<ext-link ext-link-type="uri" xlink:href="https://www.jstatsoft.org/article/view/v064i04">https://www.jstatsoft.org/article/view/v064i04</ext-link>) [<xref ref-type="bibr" rid="CR15">15</xref>]. The contagious periods were calculated as the average duration from symptom onset to laboratory confirmation, since once the infections were confirmed, they would be quarantined and not cause a secondary infection. These and other parameters and coefficients used for model simulation are based on the Notifiable Infectious Disease Reporting System and presented in Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1.</p>
                <p id="Par21">Key populations in this model were defined as the assessed stratified risk groups by exposure level in the XFD outbreak. XFD workers who were in the XFD market were assessed to be at the highest risk. They were traced through traditional epidemiologic investigation methods (i.e., face-to-face interviews or home visits) and quarantined in centralized facilities. Attack rate was calculated as the number of cases (numerator) divided by the number of total persons (denominator) presented as a percent. Attack rate among this high-risk group was 5.1%. The attack rate among workers in the BMTH was highest at 14.2%. Visitors to XFD market on June 12 were designated medium risk and quarantined in centralized facilities. They were found to have an attack rate of 0.1%. By contrast, visitors to XFD market before the outbreak (May 30–June 11) were assessed as low risk, traced by big data, and were asked to quarantine at home. The attack rate among this low-risk group was 0.02% (Table <xref rid="Tab1" ref-type="table">1</xref>). Close contacts were defined as persons who had direct contact within one meter with a confirmed case four days before or any time after their symptom onset without personal protective equipment. The close contact population was excluded from the key population.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Epidemiologic data collected for the XFD outbreak</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Categories</th><th align="left">Case numbers</th></tr></thead><tbody><tr><td align="left">Total infected cases during XFD outbreak</td><td char="." align="char">368</td></tr><tr><td align="left" colspan="2">Key population</td></tr><tr><td align="left"> Number of individuals in key population</td><td char="." align="char">546 000</td></tr><tr><td align="left"> Number of Infections identified from key population</td><td char="." align="char">272</td></tr><tr><td align="left"> Number of Infections identified via key population management</td><td char="." align="char">224</td></tr><tr><td align="left" colspan="2">Close contacts</td></tr><tr><td align="left"> Number of close contacts</td><td char="." align="char">6607</td></tr><tr><td align="left"> Number of close contacts with home-based quarantine</td><td char="." align="char">1055</td></tr><tr><td align="left"> Number of close contacts with centralized quarantine</td><td char="." align="char">5552</td></tr><tr><td align="left"> Number of infected close contacts</td><td char="." align="char">84</td></tr><tr><td align="left"> Number of infected cases identified via contact tracing</td><td char="." align="char">42</td></tr><tr><td align="left" colspan="2">Expanded nucleic acid screening</td></tr><tr><td align="left"> Number of people conducted nucleic acid screening</td><td char="." align="char">10 878 289</td></tr><tr><td align="left"> Number of Infected cases identified via expanded nucleic acid screening</td><td char="." align="char">28</td></tr><tr><td align="left" colspan="2">Other methods</td></tr><tr><td align="left"> Number of target population</td><td char="." align="char">10 111 711</td></tr><tr><td align="left"> Infected cases identified</td><td char="." align="char">76</td></tr></tbody></table></table-wrap></p>
              </sec>
              <sec id="Sec5">
                <title>Model</title>
                <p id="Par22">Our model categorized the whole population into five subpopulations, susceptible (<italic>S</italic>), exposed and infected (but not yet infectious; <italic>E</italic>), infectious (<italic>I</italic>), infectious and isolated (<italic>IS</italic>) and removed (<italic>R</italic>). Based on the actual situation in the XFD outbreak, we further divided <italic>E</italic> population into a subpopulation <italic>K</italic> indicating key population to the XFD market, a subpopulation <italic>C</italic> indicating close contacts of confirmed cases, a subpopulation <italic>N</italic> representing the infections detected by nucleic acid testing and a subpopulation <italic>O</italic> representing the infections identified by other methods. During this outbreak, a portion of the infected population was isolated early through close contact or key population tracing, or nucleic acid screening, so that it could not result in large scale secondary infection. Such infected population at the time of illness onset were classified as <italic>IS</italic> in our model. The <italic>IS</italic> group was further divided into two sub-populations according to the type of quarantine and became removed population R immediately: those who were quarantined in centralized facilities (<italic>IS</italic><sub><italic>C</italic></sub>) and those who were in home-based quarantine (<italic>IS</italic><sub><italic>H</italic></sub>). The removed population <italic>R</italic> additionally included the recovered (no deaths were reported during this outbreak). Under those assumptions, we developed a modified SEIR model illustrated in Fig. <xref rid="Fig1" ref-type="fig">1</xref>.<fig id="Fig1"><label>Fig. 1</label><caption><p>The illustration of the modified SEIR model. The model categorized the whole population into five subpopulations, susceptible (S), exposed and infected (not yet infectious) (E), infectious (I), infectious and isolated (IS) and removed (R). The IS group was further divided into two sub-populations according to the type of quarantine: those who were centralized quarantined (ISC) or home-based quarantined (ISH). E was further designated into a subpopulation K indicating key population to the XFD market, a subpopulation C indicating close contacts of confirmed cases, a subpopulation N representing the infections discovered by nucleic acid testing and a subpopulation O representing the infections identified by other methods</p></caption><graphic xlink:href="40249_2021_843_Fig1_HTML" id="MO1"/></fig></p>
                <p id="Par23">The equations are as follows:<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\frac{d{S}_{t}}{dt}=-\beta {S}_{t}({I}_{t}+I{N}_{t})-q\beta {S}_{t}IS{H}_{t},$$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="italic">dt</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mo>-</mml:mo><mml:mi>β</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>I</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mi>I</mml:mi><mml:msub><mml:mi>N</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow><mml:mo>-</mml:mo><mml:mi>q</mml:mi><mml:mi>β</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mi>I</mml:mi><mml:mi>S</mml:mi><mml:msub><mml:mi>H</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>,</mml:mo></mml:mrow></mml:math><graphic xlink:href="40249_2021_843_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\frac{d{E}_{t}}{dt}=\beta {S}_{t}\left({I}_{t}+I{N}_{t}\right)+q\beta {S}_{t}IS{H}_{t}-\gamma {E}_{t}$$\end{document}</tex-math><mml:math id="M4" display="block"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>E</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="italic">dt</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>β</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mfenced close=")" open="("><mml:msub><mml:mi>I</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mi>I</mml:mi><mml:msub><mml:mi>N</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mfenced><mml:mo>+</mml:mo><mml:mi>q</mml:mi><mml:mi>β</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mi>I</mml:mi><mml:mi>S</mml:mi><mml:msub><mml:mi>H</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:mi>γ</mml:mi><mml:msub><mml:mi>E</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:math><graphic xlink:href="40249_2021_843_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ3"><label>3</label><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\frac{d{I}_{t}}{dt}=\left(\gamma {E}_{t}-{K}_{t}-{C}_{t}-{N}_{t}\right)+\left(1-{\alpha }_{t}^{1a}-{\alpha }_{t}^{1b}-{\alpha }_{t}^{1c}-{\alpha }_{t}^{1d}-{\alpha }_{t}^{1e}-{\alpha }_{t}^{1f}\right){K}_{t}-{\sigma }_{2t}{I}_{t}$$\end{document}</tex-math><mml:math id="M6" display="block"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>I</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="italic">dt</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfenced close=")" open="("><mml:mi>γ</mml:mi><mml:msub><mml:mi>E</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>C</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mfenced><mml:mo>+</mml:mo><mml:mfenced close=")" open="("><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>a</mml:mi></mml:mrow></mml:msubsup><mml:mo>-</mml:mo><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>b</mml:mi></mml:mrow></mml:msubsup><mml:mo>-</mml:mo><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>c</mml:mi></mml:mrow></mml:msubsup><mml:mo>-</mml:mo><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>d</mml:mi></mml:mrow></mml:msubsup><mml:mo>-</mml:mo><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>e</mml:mi></mml:mrow></mml:msubsup><mml:mo>-</mml:mo><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>f</mml:mi></mml:mrow></mml:msubsup></mml:mfenced><mml:msub><mml:mi>K</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>I</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:math><graphic xlink:href="40249_2021_843_Article_Equ3.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ4"><label>4</label><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\frac{d{IN}_{t}}{dt}={N}_{t}-{\sigma }_{3t}{IN}_{t}$$\end{document}</tex-math><mml:math id="M8" display="block"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi mathvariant="italic">IN</mml:mi></mml:mrow><mml:mi>t</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="italic">dt</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="italic">IN</mml:mi></mml:mrow><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:math><graphic xlink:href="40249_2021_843_Article_Equ4.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ5"><label>5</label><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\frac{d{ISC}_{t}}{dt}=\left(1-{h}_{t}^{2}\right){C}_{t}+\left({\alpha }_{t}^{1a}+{\alpha }_{t}^{1b}+{\alpha }_{t}^{1c}+{\alpha }_{t}^{1d}\right){K}_{t}-{\sigma }_{1t}{ISC}_{t}$$\end{document}</tex-math><mml:math id="M10" display="block"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi mathvariant="italic">ISC</mml:mi></mml:mrow><mml:mi>t</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="italic">dt</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mfenced close=")" open="("><mml:mn>1</mml:mn><mml:mo>-</mml:mo><mml:msubsup><mml:mi>h</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:mfenced><mml:msub><mml:mi>C</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mfenced close=")" open="("><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>a</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>b</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>c</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>d</mml:mi></mml:mrow></mml:msubsup></mml:mfenced><mml:msub><mml:mi>K</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="italic">ISC</mml:mi></mml:mrow><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:math><graphic xlink:href="40249_2021_843_Article_Equ5.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ6"><label>6</label><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\frac{d{ISH}_{t}}{dt}={h}_{t}^{2}{C}_{t}+\left({\alpha }_{t}^{1e}+{\alpha }_{t}^{1f}\right){K}_{t}-{\sigma }_{1t}{ISH}_{t}$$\end{document}</tex-math><mml:math id="M12" display="block"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mrow><mml:mi mathvariant="italic">ISH</mml:mi></mml:mrow><mml:mi>t</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="italic">dt</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msubsup><mml:mi>h</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup><mml:msub><mml:mi>C</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mfenced close=")" open="("><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>e</mml:mi></mml:mrow></mml:msubsup><mml:mo>+</mml:mo><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>f</mml:mi></mml:mrow></mml:msubsup></mml:mfenced><mml:msub><mml:mi>K</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="italic">ISH</mml:mi></mml:mrow><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:math><graphic xlink:href="40249_2021_843_Article_Equ6.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ7"><label>7</label><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\frac{d{R}_{t}}{dt}={\sigma }_{2t}{I}_{t}+{\sigma }_{3t}{IN}_{t}+{\sigma }_{1t}\left({ISC}_{t}+IS{H}_{t}\right)$$\end{document}</tex-math><mml:math id="M14" display="block"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>R</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow><mml:mrow><mml:mi mathvariant="italic">dt</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mn>2</mml:mn><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>I</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mn>3</mml:mn><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mrow><mml:mi mathvariant="italic">IN</mml:mi></mml:mrow><mml:mi>t</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>σ</mml:mi><mml:mrow><mml:mn>1</mml:mn><mml:mi>t</mml:mi></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:msub><mml:mrow><mml:mi mathvariant="italic">ISC</mml:mi></mml:mrow><mml:mi>t</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mi>I</mml:mi><mml:mi>S</mml:mi><mml:msub><mml:mi>H</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="40249_2021_843_Article_Equ7.gif" position="anchor"/></alternatives></disp-formula></p>
                <p id="Par24">In the equation, <italic>K</italic><sub><italic>t</italic></sub> indicates the daily infections from the key population in XFD market, and <inline-formula id="IEq1"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\alpha }_{t}^{1a}, {\alpha }_{t}^{1b},{\alpha }_{t}^{1c},{\alpha }_{t}^{1d},{\alpha }_{t}^{1e} and {\alpha }_{t}^{1f}$$\end{document}</tex-math><mml:math id="M16"><mml:mrow><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>a</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>b</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>c</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>d</mml:mi></mml:mrow></mml:msubsup><mml:mo>,</mml:mo><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>e</mml:mi></mml:mrow></mml:msubsup><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>d</mml:mi><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mrow><mml:mn>1</mml:mn><mml:mi>f</mml:mi></mml:mrow></mml:msubsup></mml:mrow></mml:math><inline-graphic xlink:href="40249_2021_843_Article_IEq1.gif"/></alternatives></inline-formula> are the proportions of the daily infections in group 1.1 to group 3.2 (Table <xref rid="Tab2" ref-type="table">2</xref>) of the total daily number in key population, respectively. <inline-formula id="IEq2"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${C}_{t}= {\alpha }_{2}^{t}(\gamma {E}_{t}-{K}_{t})$$\end{document}</tex-math><mml:math id="M18"><mml:mrow><mml:msub><mml:mi>C</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mi>t</mml:mi></mml:msubsup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>γ</mml:mi><mml:msub><mml:mi>E</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math><inline-graphic xlink:href="40249_2021_843_Article_IEq2.gif"/></alternatives></inline-formula> indicates the daily infections discovered by close contact tracing, while parameter <inline-formula id="IEq3"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\alpha }_{t}^{2}$$\end{document}</tex-math><mml:math id="M20"><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:math><inline-graphic xlink:href="40249_2021_843_Article_IEq3.gif"/></alternatives></inline-formula> models the effect of the close contact tracing and management. It is the proportion of the daily infections of the daily total number from close contacts, excluding the cases from the key population of the XFD market. <inline-formula id="IEq4"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${N}_{t}= {\alpha }_{3}^{t}(\gamma {E}_{t}-{K}_{t})$$\end{document}</tex-math><mml:math id="M22"><mml:mrow><mml:msub><mml:mi>N</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mn>3</mml:mn></mml:mrow><mml:mi>t</mml:mi></mml:msubsup><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:mi>γ</mml:mi><mml:msub><mml:mi>E</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>K</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo></mml:mrow></mml:mrow></mml:math><inline-graphic xlink:href="40249_2021_843_Article_IEq4.gif"/></alternatives></inline-formula> indicates the daily infections found by expanded nucleic acid screening, while parameter <inline-formula id="IEq5"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\alpha }_{t}^{3}$$\end{document}</tex-math><mml:math id="M24"><mml:msubsup><mml:mi>α</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mn>3</mml:mn></mml:msubsup></mml:math><inline-graphic xlink:href="40249_2021_843_Article_IEq5.gif"/></alternatives></inline-formula> models the effect of the expanded nucleic acid screening. It is the infection proportion of daily total number from expanded nucleic acid screening, excluding the cases from the key population of the XFD market. Parameter <inline-formula id="IEq6"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\sigma }_{t}$$\end{document}</tex-math><mml:math id="M26"><mml:msub><mml:mi>σ</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="40249_2021_843_Article_IEq6.gif"/></alternatives></inline-formula> represents the speed of transition from the infectious to the removed. Since all the infectious cases/infections were isolated in designated hospitals or home once confirmed, <inline-formula id="IEq7"><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${\sigma }_{t}$$\end{document}</tex-math><mml:math id="M28"><mml:msub><mml:mi>σ</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="40249_2021_843_Article_IEq7.gif"/></alternatives></inline-formula> represents the speed of transition from the infectious to the confirmed. It equals the reciprocal of the time difference between the disease onset and confirmation. Parameter <inline-formula id="IEq8"><alternatives><tex-math id="M29">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${h}_{t}^{2}$$\end{document}</tex-math><mml:math id="M30"><mml:msubsup><mml:mi>h</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mn>2</mml:mn></mml:msubsup></mml:math><inline-graphic xlink:href="40249_2021_843_Article_IEq8.gif"/></alternatives></inline-formula> is the percentage of cases who were home-isolated among all the cases identified by closed contact tracing. These parameter values were abstracted from epidemiologic data (Tables <xref rid="Tab1" ref-type="table">1</xref>, <xref rid="Tab2" ref-type="table">2</xref>, Additional file <xref rid="MOESM1" ref-type="media">1</xref>: Table S1).<table-wrap id="Tab2"><label>Table 2</label><caption><p>Group of key population and attack rate of each group</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Group</th><th align="left">Exposed populations</th><th align="left">Quarantine protocol</th><th align="left">Tracing techniques</th><th align="left">Risk level</th><th align="left">Total no</th><th align="left">No. of cases</th><th align="left">Attack rate (%)</th></tr></thead><tbody><tr><td char="." align="char">1</td><td align="left">Workers at the XFD market</td><td align="left">Centralized quarantine</td><td align="left">Onsite</td><td align="left">High</td><td char="." align="char">3311</td><td char="." align="char">169</td><td char="." align="char">5.10</td></tr><tr><td char="." align="char">1.1</td><td align="left">Workers at the BMTH</td><td align="left">Centralized quarantine</td><td align="left">Onsite</td><td align="left">High</td><td char="." align="char">838</td><td char="." align="char">119</td><td char="." align="char">14.20</td></tr><tr><td char="." align="char">1.2</td><td align="left">Workers at the XFD market other than BMTH</td><td align="left">Centralized quarantine</td><td align="left">Onsite</td><td align="left">High</td><td char="." align="char">2473</td><td char="." align="char">50</td><td char="." align="char">2.02</td></tr><tr><td char="." align="char">2</td><td align="left">Visitors to the XFD market on June 12th</td><td align="left">Centralized quarantine</td><td align="left">Onsite</td><td align="left">Medium</td><td char="." align="char">7689</td><td char="." align="char">8</td><td char="." align="char">0.10</td></tr><tr><td char="." align="char">2.1</td><td align="left">Visitors to the BMTH market</td><td align="left">Centralized quarantine</td><td align="left">Onsite</td><td align="left">Medium</td><td char="." align="char">1078</td><td char="." align="char">8</td><td char="." align="char">0.74</td></tr><tr><td char="." align="char">2.2</td><td align="left">Visitors to the XFD market other than BMTH</td><td align="left">Centralized quarantine</td><td align="left">Onsite</td><td align="left">Medium</td><td char="." align="char">6611</td><td char="." align="char">0</td><td char="." align="char">0</td></tr><tr><td char="." align="char">3</td><td align="left">Visitors to XFD between May 30th and June 11th</td><td align="left">Home quarantine</td><td align="left">Big data</td><td align="left">Low</td><td char="." align="char">535 000</td><td char="." align="char">95</td><td char="." align="char">0.02</td></tr><tr><td char="." align="char">3.1</td><td align="left">Visitors to the BMTH market</td><td align="left">Home quarantine</td><td align="left">Big data</td><td align="left">Low</td><td char="." align="char">75 000</td><td char="." align="char">64</td><td char="." align="char">0.09</td></tr><tr><td char="." align="char">3.2</td><td align="left">Visitors to the XFD market other than BMTH</td><td align="left">Home quarantine</td><td align="left">Big data</td><td align="left">Low</td><td char="." align="char">460 000</td><td char="." align="char">31</td><td char="." align="char">0.007</td></tr></tbody></table><table-wrap-foot><p><italic>BMTH</italic> Beef and Mutton Trading Hall,<italic> XFD</italic> Xinfadi</p></table-wrap-foot></table-wrap></p>
                <p id="Par25">Parameter <inline-formula id="IEq9"><alternatives><tex-math id="M31">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M32"><mml:mi>β</mml:mi></mml:math><inline-graphic xlink:href="40249_2021_843_Article_IEq9.gif"/></alternatives></inline-formula> is the transmission rate. Parameter <inline-formula id="IEq10"><alternatives><tex-math id="M33">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$q$$\end{document}</tex-math><mml:math id="M34"><mml:mi>q</mml:mi></mml:math><inline-graphic xlink:href="40249_2021_843_Article_IEq10.gif"/></alternatives></inline-formula> denotes the reduction of infectiousness for home-quarantined patients compared to non-quarantined patients. We estimated <inline-formula id="IEq11"><alternatives><tex-math id="M35">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M36"><mml:mi>β</mml:mi></mml:math><inline-graphic xlink:href="40249_2021_843_Article_IEq11.gif"/></alternatives></inline-formula> and <inline-formula id="IEq12"><alternatives><tex-math id="M37">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$q$$\end{document}</tex-math><mml:math id="M38"><mml:mi>q</mml:mi></mml:math><inline-graphic xlink:href="40249_2021_843_Article_IEq12.gif"/></alternatives></inline-formula> by Markov Chain Monte Carlo (MCMC) with the Adaptive Metropolis algorithm implemented in the Python package <italic>PyMC</italic> (version 2.3.8) [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. We used a non-informative flat prior of Uniform (9e-9, 5e-4) for <inline-formula id="IEq13"><alternatives><tex-math id="M39">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M40"><mml:mi>β</mml:mi></mml:math><inline-graphic xlink:href="40249_2021_843_Article_IEq13.gif"/></alternatives></inline-formula>, and Uniform (0.01, 1.0) for <inline-formula id="IEq14"><alternatives><tex-math id="M41">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$q$$\end{document}</tex-math><mml:math id="M42"><mml:mi>q</mml:mi></mml:math><inline-graphic xlink:href="40249_2021_843_Article_IEq14.gif"/></alternatives></inline-formula>. We fitted the model with data of cumulative cases from June 6 to July 10, 2020, by the date of symptom onset. After a burn-in of 1,000 iterations, we ran the MCMC simulation for 30,000 iterations with a sampling size of each 10 iterations. The RMSE of cases from June 6 to July 10 between model prediction and observation is 16.61. All of these analyses were performed in Python (version 3.6.0 <ext-link ext-link-type="uri" xlink:href="https://www.python.org/">https://www.python.org/</ext-link>).</p>
              </sec>
              <sec id="Sec6">
                <title>Simulated scenarios</title>
                <sec id="Sec7">
                  <title>Timing of initiation comprehensive measures</title>
                  <p id="Par26">We hypothesized that delays in the implementation of the NPI, infection source intervention, would result in higher magnitude of transmission and later endpoint of transmission. Therefore, we modeled a 3 day, 7 day, and 14 day delay or ahead of the timing of infection source identification. We compared these predicted results with the actual outcomes from the XFD outbreak response: 368-case transmission magnitude and July 10 transmission endpoint. We assumed that: (1) unlimited health resources, (2) all other NPIs implemented precisely as in the real outbreak response, and (3) the proportion of each group of key population in Table <xref rid="Tab2" ref-type="table">2</xref> remains unchanged. We also changed the timing of other NPIs accordingly in model simulation (timing of the closure of XFD market, quarantining of key population, close contact tracing, expanded nucleic acid screening).</p>
                </sec>
                <sec id="Sec8">
                  <title>Management of key population</title>
                  <p id="Par27">There were 224 confirmed infections identified in all managed key population. We simulated the epidemic development under quarantine protocols to the market workers or visitors to the market, respectively. In our simulation, for simplicity, we assumed that other NPI measures were independently unchanged when evaluating the effectiveness of each NPI measure of interest.</p>
                </sec>
                <sec id="Sec9">
                  <title>Quarantine of traced close contacts</title>
                  <p id="Par28">There were 42 confirmed infections identified among close contacts group. For close contacts tracing, we compared the effect of centralized quarantine versus home quarantine.</p>
                </sec>
                <sec id="Sec10">
                  <title>Expanded screening for the general population</title>
                  <p id="Par29">There were 28 confirmed infections identified from expanded screening in the general population. Expanded nucleic acid screening was expanded from the center of the XFD outbreak to surroundings among the general population. We simulated the effect of timing of nucleic acid test with 3 or 7 days delayed or in advance.</p>
                  <p id="Par30">For all scenarios, we repeated the simulations based on parameter values estimated by 30 000 MCMC iterations with sampling at each 10 steps (i.e., 3000 samples totally) to construct the 95% confidence intervals (95% <italic>CI</italic>) of the epidemic curve by the 2.5 and 97.5 percentiles at each time point. The simulation results were presented as mean values and 95% <italic>CI</italic> calculated from the 3000 MCMC samples in this study. All the analyses were conducted using Python software, version 3.6.0.</p>
                </sec>
              </sec>
              <sec id="Sec11">
                <title>Sharing</title>
                <p id="Par31">The data used in this study are from public accessible database, internal databases from Beijing CDC, as well as news briefings. The mathematic model and code used for the analysis are available by addressing to the corresponding authors.</p>
              </sec>
            </sec>
            <sec id="Sec12">
              <title>Results</title>
              <sec id="Sec13">
                <title>Timing of combination NPI implementation</title>
                <p id="Par32">According to our model, a 3 day delay from the actual timing with which combination NPI response measures were initiated (i.e., identification of XFD as the infection source and initiation of NPIs) would lead to a threefold increase in the magnitude of transmission (95% <italic>CI</italic>: 2.6–3.4; i.e., 1104 vs 368 cases). A 7 day delay would lead to a 7.5-fold increase in the magnitude of transmission (95% <italic>CI</italic>: 6.4–8.6; 2768 vs 368 cases) and a 14 day delay a 28.2-fold increase (95% <italic>CI</italic>: 23.2–33.3; i.e., 10 411 vs 368 cases). Finally, these delays would also lead to endpoints of transmission delayed by 31, 50, and 77 days, respectively (Table <xref rid="Tab3" ref-type="table">3</xref>, Fig. <xref rid="Fig2" ref-type="fig">2</xref>a and a′).<table-wrap id="Tab3"><label>Table 3</label><caption><p>Results of scenario simulations on two outcomes: magnitude of transmission and endpoint of transmission</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left"/><th align="left" colspan="4">Magnitude of transmission</th><th align="left">Endpoint of transmission</th></tr><tr><th align="left">Scenarios simulated</th><th align="left">Number of cases (95% <italic>CI</italic>)</th><th align="left">Relative increase fold (95% <italic>CI</italic>)</th><th align="left">Number of cases in target-population (95% <italic>CI</italic>)</th><th align="left">Relative increase fold (95% <italic>CI</italic>)</th><th align="left">Date of containment (Relative delay)</th></tr></thead><tbody><tr><td align="left" colspan="6">Timing of initiation comprehensive measures</td></tr><tr><td align="left"> Reality: Delayed 0 days</td><td align="left">368</td><td align="left">-</td><td align="left">368</td><td align="left"/><td align="left">July 10</td></tr><tr><td align="left"> Scenario 1: Delayed 3 days</td><td align="left">1104 (947–1261)</td><td align="left">3.0 (2.6–3.4)</td><td align="left">1104 (947–1261)</td><td align="left">3.0 (2.6–3.4)</td><td align="left">August 10 (31 days)</td></tr><tr><td align="left"> Scenario 2: Delayed 7 days</td><td align="left">2768 (2360–3176)</td><td align="left">7.5 (6.4–8.6)</td><td align="left">2768 (2360–3176)</td><td align="left">7.5 (6.4–8.6)</td><td align="left">August 29 (50 days)</td></tr><tr><td align="left"> Scenario 3: Delayed 14 days</td><td align="left">10,411 (8549–12,272)</td><td align="left">28.2 (23.2–33.3)</td><td align="left">10 411 (8549–12 272)</td><td align="left">28.2 (23.2–33.3)</td><td align="left">September 25 (77 days)</td></tr><tr><td align="left" colspan="6">Management of Key Population</td></tr><tr><td align="left"> Reality:</td><td align="left">368</td><td align="left">-</td><td align="left">224</td><td align="left"/><td align="left">July 10</td></tr><tr><td align="left"> Scenario 1: No quarantine</td><td align="left">1,969 (1,658–2,280)</td><td align="left">5.5 (4.5–6.2)</td><td align="left">1825 (1514–2136)</td><td align="left">8.2 (6.8–9.5)</td><td align="left">September 21 (73 days)</td></tr><tr><td align="left"> Scenario 2: Quarantine high-medium risk</td><td align="left">640 (536–744)</td><td align="left">1.7 (1.5–2.0)</td><td align="left">496 (392–600)</td><td align="left">2.2 (1.8–2.7)</td><td align="left">August 18 (39 days)</td></tr><tr><td align="left" colspan="6">Quarantine of traced close contacts</td></tr><tr><td align="left"> Reality: Centralized and home quarantine</td><td align="left">368</td><td align="left"/><td align="left">42</td><td align="left"/><td align="left">July 10</td></tr><tr><td align="left">  Scenario 1: No quarantine</td><td align="left">727 (609–844)</td><td align="left">2.0 (1.7–2.3)</td><td align="left">401 (283–518)</td><td align="left">9.5 (6.7–12.3)</td><td align="left">August 23 (44 days)</td></tr><tr><td align="left">Scenario 2: Centralized quarantine for all</td><td align="left">361 (330–392)</td><td align="left">1.0 (0.9–1.1)</td><td align="left">35 (4–66)</td><td align="left">0.8 (0.1–1.6)</td><td align="left">July 5 (-5 days)</td></tr><tr><td align="left"> Scenario 3: Home quarantine for all</td><td align="left">382 (341–423)</td><td align="left">1.0 (0.9–1.2)</td><td align="left">56 (15–97)</td><td align="left">1.3 (0.3–2.3)</td><td align="left">July 14 (4 days)</td></tr><tr><td align="left" colspan="6">Expanded nucleic acid screening in the general population</td></tr><tr><td align="left"> Reality:</td><td align="left">368</td><td align="left"/><td align="left">28</td><td align="left"/><td align="left"/></tr><tr><td align="left"> Scenario 1: Accelerated 7 days</td><td align="left">332 (305–358)</td><td align="left">0.9 (0.8–1.0)</td><td align="left">-8 (-35–18)</td><td align="left">0</td><td align="left">July 7 (-3 days)</td></tr><tr><td align="left"> Scenario 2: Accelerated 3 days</td><td align="left">352 (319–384)</td><td align="left">1.0 (0.9–1.0)</td><td align="left">12 (-21–44)</td><td align="left">0.4 (0–1.6)</td><td align="left">July 8 (-2 days)</td></tr><tr><td align="left"> Scenario 3: Delayed 3 days</td><td align="left">429 (377 to 481)</td><td align="left">1.2 (1.0–1.3)</td><td align="left">89 (37–141)</td><td align="left">3.2 (1.3–5)</td><td align="left">July 18 (8 days)</td></tr><tr><td align="left"> Scenario 4: Delayed 7 days</td><td align="left">487 (405 to 568)</td><td align="left">1.3 (1.1–1.5)</td><td align="left">147 (65–228)</td><td align="left">5.3 (2.3–8.1)</td><td align="left">July 27 (17 days)</td></tr><tr><td align="left"> Scenario 5: No Nucleic Acid Screening</td><td align="left">603 (516 to 690)</td><td align="left">1.6 (1.4–1.8)</td><td align="left">263 (176–350)</td><td align="left">9.4 (6.3–12.5)</td><td align="left">August 11 (32 days)</td></tr></tbody></table><table-wrap-foot><p><italic>CI</italic> Confidence interval</p></table-wrap-foot></table-wrap><fig id="Fig2"><label>Fig. 2</label><caption><p>Scenario model simulation to assess the timing of intervention, management of key populations, contact tracing and expanded SARS CoV-2 Nucleic Acid screening. (<bold>a</bold>) and (<bold>a’</bold>) daily and cumulated total case number with the 3 day, 7 day, and 14 day delayed identification of XFD market as the </p><p>source of infection. (<bold>b</bold>) and (<bold>b’</bold>) daily and cumulated total case number simulated for management on the key population to the XFD market. (<bold>c</bold>) and (<bold>c’</bold>) daily and cumulated total case number simulated for the close contacts traced with different quarantine protocols. (<bold>d</bold>) and (<bold>d’</bold>) daily and cumulated total case number simulated for delayed or earlier expanded Nucleic acid screening on general population. Shading areas indicate 95% confidence intervals</p></caption><graphic xlink:href="40249_2021_843_Fig2_HTML" id="MO2"/></fig></p>
              </sec>
              <sec id="Sec14">
                <title>Management of key populations</title>
                <p id="Par33">Similarly, if no quarantine was instituted, the magnitude of transmission would be 5.5-fold greater (95% <italic>CI</italic>: 4.5–6.2; i.e., 1969 vs 368 cases) and the endpoint of transmission would be delayed 73 days compared to reality. If only the high- and medium-risk populations (i.e., Group 1 and Group 2) were quarantined, the magnitude of transmission would be 1.7-fold greater (95% <italic>CI</italic>:1.5–2.0; 640 versus 368 cases) and the endpoint of transmission would be delayed 39 days (Table <xref rid="Tab3" ref-type="table">3</xref>, Fig. <xref rid="Fig2" ref-type="fig">2</xref>b and b′). If just the targeted key population is modeled, no quarantine would lead to 8.2-fold greater (95% <italic>CI</italic>: 6.8–9.5; i.e., 1825 vs 224 cases) magnitude of transmission and quarantine only for high- and medium-risk populations, a 2.2-fold greater (95% <italic>CI</italic>: 1.8–2.7; i.e., 496 vs 224 cases) magnitude of transmission (Table <xref rid="Tab3" ref-type="table">3</xref>).</p>
              </sec>
              <sec id="Sec15">
                <title>Quarantine of traced close contacts</title>
                <p id="Par34">According to our model, no quarantine for close contacts would result in twofold greater (95% <italic>CI</italic>: 1.7–2.3; i.e., 727 vs 368 cases) magnitude of transmission and a 44 day delay in the endpoint of transmission. A more rigorous all-centralized quarantine for close contacts would result in 1.0-fold (95% <italic>CI</italic>: 0.9–1.1; i.e., 361 vs 368 cases) the magnitude of transmission and a 5 day acceleration in the endpoint of transmission. By contrast, a less rigorous all-home quarantine for close contacts would result in 1.0-fold greater (95% <italic>CI</italic>: 0.9–1.2; i.e., 382 vs 368 cases) magnitude of transmission and a 4 day delay in the endpoint of transmission (Table <xref rid="Tab3" ref-type="table">3</xref>, and Fig. <xref rid="Fig2" ref-type="fig">2</xref>c and c′). If just the targeted key population is modeled, no quarantine for close contacts results in 9.5-fold greater (95% <italic>CI</italic>: 6.7–12.3; 401 vs 42 cases) magnitude of transmission. More rigorous all-centralized quarantine for close contacts would result in 0.8-fold (95% <italic>CI</italic>: 0.1–1.6; 35 vs 42 cases) the magnitude of transmission whereas less rigorous all-home quarantine would result in 1.3-fold (95% <italic>CI:</italic> 0.3–2.3; 56 vs 42 cases) the magnitude of transmission (Table <xref rid="Tab3" ref-type="table">3</xref>).</p>
              </sec>
              <sec id="Sec16">
                <title>Expanded nucleic acid screening in the general population</title>
                <p id="Par35">According to our model, implementation of expanded nucleic acid screening 7 days earlier would result in 0.9-fold (95% <italic>CI</italic>: 0.8–1.0; 332 vs 368 cases) the magnitude of transmission and endpoint of transmission accelerated by three days. Three days earlier would result in 1.0-fold (95% <italic>CI</italic>: 0.9–1.0; 352 vs 368 cases) the magnitude of transmission and endpoint of transmission accelerated by two days. By contrast, a 3 day delay would result in 1.2-fold greater (95% <italic>CI</italic>: 1.0–1.3; 429 vs 368 cases) magnitude of transmission and an 8 day delay to the endpoint of transmission. A 7 day delay would result in 1.3-fold greater (95% <italic>CI</italic>: 1.1–1.5; 487 vs 368 cases) magnitude of transmission and a 17 day delay to the endpoint of transmission. Finally, no implementation of expanded nucleic acid screening at all would result in 1.6-fold greater (95% <italic>CI</italic>: 1.4–1.8; 603 vs 368 cases) magnitude of transmission and a 32 day delay to the endpoint of transmission (Table <xref rid="Tab3" ref-type="table">3</xref>, and Fig. <xref rid="Fig2" ref-type="fig">2</xref>d and d′). If just the targeted key population is modeled, a 3 day acceleration yields 0.4-fold (95% <italic>CI</italic>: 0.0–1.6; 12 vs 28 cases) the magnitude of transmission whereas a 3 day delay yields 3.2-fold greater (95% <italic>CI</italic>: 1.3–5; 89 vs 28 cases) magnitude of transmission, a 7 day delay results in a 5.3-fold greater (95% <italic>CI</italic>: 2.3–8.1; 147 vs 28 cases) magnitude of transmission, and no implementation at all yields a 9.4-fold greater (95% <italic>CI</italic>: 6.3–12.5; 263 vs 28 cases) magnitude of transmission (Table <xref rid="Tab3" ref-type="table">3</xref>).</p>
              </sec>
            </sec>
            <sec id="Sec17">
              <title>Discussion</title>
              <p id="Par36">Our results revealed that the delay in the identification of XFD as the infection source, subsequently leading a delay initiation of NPIs would have caused folds increase in transmission and months delay in the resurgence containment. A failure to implement the quarantine scheme employed in the XFD outbreak for at-risk groups would have caused greater transmission and more than two months of delay to containment. Similarly, failure to implement the quarantine plan executed in the XFD outbreak for close contacts would have caused greater transmission and a more than one month delay to containment. Finally, failure to implement expanded nucleic acid screening would have yielded greater transmission and about one month delay to containment. The evidence should inform suggestions to future resurgence outbreaks of COVID-19 and infectious disease outbreak preparedness efforts in China and worldwide.</p>
              <p id="Par37">Among the 272 infections found among the ~ 546 thousand individuals in defined key populations, 224 (82.4%) were identified through key population management while just 48 (17.6%) were identified through healthcare seeking, contact tracing, expanded nucleic acid screening, or other methods. Our results show that failure to manage these key populations would have caused an eightfold increase in number of cases and a 2 month delay to containment, indicating that this NPI is crucial. It is furthermore important to note that this kind of intervention requires no sample collection, no laboratory testing, and no detailed epidemiological investigation. Rather, it is practical, straightforward, and highly targeted.</p>
              <p id="Par38">More recently, the cities of Wuhan and Qingdao in China have undertaken population-wide nucleic acid screening for SARS-CoV-2 among all residents in the cities, but this kind of action is costly and thus controversial [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>]. To be practical, real-time risk assessments must be paired with expanded nucleic acid screening so that efficiency is optimized. To control costs yet identify infections with maximum efficiency, the authorities in Beijing applied nucleic acid screening with real-time adjustment based on risk levels, expanding screening from the epicenter, XFD market, to surroundings gradually and ending it when the daily positivity rate fell to zero. Although our results seemed to indicate only a small 1.6-fold increase in transmission with failure to implement expanded nucleic acid screening, a 9.4-fold increase was predicted by our model for the key populations if no nucleic acid screening was conducted in the general population. Considering improved efficiency of expanded screening when coupled with ongoing risk assessment, this NPI should also be considered important for achieving containment of a COVID-19 outbreak.</p>
              <p id="Par39">Management of close contacts, whether in home or centralized quarantine, is also a controversial topic. Yet, close contact management has been proven to be effective [<xref ref-type="bibr" rid="CR20">20</xref>]. While home quarantine is more likely to cause secondary cases than centralized quarantine [<xref ref-type="bibr" rid="CR20">20</xref>], centralized quarantine is much costlier. Moreover, centralized quarantine might trigger infection cluster, or even outbreak if the prevention and control measures are not effectively performed. Considering the cost of quarantine and the quality of life for quarantined persons, home-quarantine could be recommended if it could be conducted strictly.</p>
              <p id="Par40">This study has some limitations. In our simulations, we assumed that resources were adequate and all the NPIs were effectively implemented even as the numbers of cases surged. In reality, as disease transmission increased, some resources (e.g., centralized quarantine facilities) would be depleted and eventually reach a shortage. In addition, for simplicity, we assessed one NPI at a time, assuming the others would not be impacted. However, in reality, there are interdependencies between NPIs and the ability for officials to manipulate just one NPI alone at a time is limited. We also only evaluated two outcomes (i.e., magnitude and endpoint of transmission). Although these two are important with respect to containment, they fail to take other factors into account and ignore other outcomes of interest. Further study should be conducted using this model to evaluate the NPIs in different ways. For example, expanded nucleic acid screening in the general population appeared in our results to have only a small impact on the magnitude and endpoint of transmission. However, the extremely low positivity rate among the general population helped accelerate re-normalization and return to routine economic activity and social life in Beijing, limiting the negative consequences of anti-COVID-19 response activities. This socioeconomic benefit should be considered when evaluating NPIs in the future. Finally, social and culture factors also contributed to the success of containment efforts in the XFD market outbreak. Even though COVID-19 in China was at low level of transmission, and no new infections had been found in Beijing for nearly two months, residents were still wearing masks, obeying social distancing recommendations, and taking other personal prevention measures. They were also aware of the danger of SARS-CoV-2 infection. Thus, implementation of NPIs in the XFD outbreak was relatively well accepted, which may differ from circumstances in other settings in which this model may be applied.</p>
            </sec>
            <sec id="Sec18">
              <title>Conclusions</title>
              <p id="Par41">This modeling study provides important new evidence that can not only in form the selection of NPI to use as countermeasures in response to a COVID-19 outbreak but also can inform the optimal timing of their implementation. Moreover, this study clearly calculates the consequences of inaction and hesitation on the part of outbreak response teams and decision-making officials. This evidence should inform responses to future outbreaks of COVID-19 and future infectious disease outbreak preparedness efforts in China. Additionally, these lessons and this methodology can be used by other nations as they work to improve their anti-COVID-19 strategies and tactics.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Information</title>
              <sec id="Sec19">
                <p>
                  <supplementary-material content-type="local-data" id="MOESM1">
                    <media xlink:href="40249_2021_843_MOESM1_ESM.docx">
                      <caption>
                        <p><bold>Additional file 1: Table S1</bold>. Parameters and coefficients for model simulation.</p>
                      </caption>
                    </media>
                  </supplementary-material>
                </p>
              </sec>
            </sec>
          </body>
          <back>
            <glossary>
              <title>Abbreviations</title>
              <def-list>
                <def-item>
                  <term>Beijing CDC</term>
                  <def>
                    <p id="Par5">Beijing Center for Disease Prevention and Control</p>
                  </def>
                </def-item>
                <def-item>
                  <term>BMTH</term>
                  <def>
                    <p id="Par6">Beef and Mutton Trading Hall</p>
                  </def>
                </def-item>
                <def-item>
                  <term>
                    <italic>CI</italic>
                  </term>
                  <def>
                    <p id="Par7">Confidence interval</p>
                  </def>
                </def-item>
                <def-item>
                  <term>COVID-19</term>
                  <def>
                    <p id="Par8">Coronavirus disease 2019</p>
                  </def>
                </def-item>
                <def-item>
                  <term>MCMC</term>
                  <def>
                    <p id="Par9">Markov Chain Monte Carlo</p>
                  </def>
                </def-item>
                <def-item>
                  <term>NPI</term>
                  <def>
                    <p id="Par10">Non-pharmaceutical intervention</p>
                  </def>
                </def-item>
                <def-item>
                  <term>RMSE</term>
                  <def>
                    <p id="Par11">Root-mean-square error</p>
                  </def>
                </def-item>
                <def-item>
                  <term>SARS-CoV-2</term>
                  <def>
                    <p id="Par12">Severe acute respiratory syndrome coronavirus 2</p>
                  </def>
                </def-item>
                <def-item>
                  <term>SEIR</term>
                  <def>
                    <p id="Par13">Susceptible–exposed–infectious–recovered</p>
                  </def>
                </def-item>
                <def-item>
                  <term>XFD</term>
                  <def>
                    <p id="Par14">Xinfadi</p>
                  </def>
                </def-item>
              </def-list>
            </glossary>
            <fn-group>
              <fn>
                <p>Xiao-Li Wang, Xin Lin and Peng Yang contributed equally to this work</p>
              </fn>
            </fn-group>
            <ack>
              <title>Acknowledgements</title>
              <p>The authors would like to thank Chenxu Yu, Li Guo, Kangning Cai and Zhida Cheng from Yidu Cloud (Beijing) Technology Co., Ltd, for helping data collection and cleaning, manuscript revision and figure illustrations.</p>
            </ack>
            <notes notes-type="author-contribution">
              <title>Authors' contributions</title>
              <p>XW, ZW, QW, PY, and CH conceived the study and were in charge of overall direction and planning. XL, JW, XW, SL, ZJ, GL, and HS designed the modified SEIR model and performed the computations. XW, XH, JMM, KC, and SL wrote the manuscript. All authors read and approved the final manuscript.</p>
            </notes>
            <notes notes-type="funding-information">
              <title>Funding</title>
              <p>This study was funded by grants from Beijing Science and Technology Planning Project (Z201100005420010) and Beijing Talent Project (2020A50). The work was partially supported by the National Key R&amp;D Program of China (2019YFB2102103), the National Natural Science Foundation of China (Grant No. 92046010, 82161148011).</p>
            </notes>
            <notes notes-type="data-availability">
              <title>Availability of data and materials</title>
              <p>The data used in this study were extracted from the Notifiable Infectious Disease Reporting System (basic individual case-level demographics, location, and diagnostic data), the Epidemiological Investigation Information System (detailed individual case-level exposure, symptom, and clinical data), and the Close Contacts Tracing and Management System (individual contact-level demographics, exposures, location, and quarantine data) [<xref ref-type="bibr" rid="CR15">15</xref>].</p>
            </notes>
            <notes>
              <title>Declarations</title>
              <notes id="FPar1">
                <title>Ethics approval and consent to participate</title>
                <p id="Par42">Ethical approval and informed consent requirements were waived by the Institutional Review Board and Human Research Ethics Committee of the Beijing Center for Disease Prevention and Control (Beijing CDC) because this study was considered a continuation of the public health investigation associated with an emerging infectious disease.</p>
              </notes>
              <notes id="FPar2">
                <title>Consent for publication</title>
                <p id="Par43">Not applicable.</p>
              </notes>
              <notes id="FPar3" notes-type="COI-statement">
                <title>Competing interests</title>
                <p id="Par44">The authors declare that they have no competing interests.</p>
              </notes>
            </notes>
            <ref-list id="Bib1">
              <title>References</title>
              <ref id="CR1">
                <label>1.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Brauner</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Mindermann</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Sharma</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Johnston</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Salvatier</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Gavenčiak</surname>
                      <given-names>T</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Inferring the effectiveness of government interventions against COVID-19</article-title>
                  <source>Science</source>
                  <year>2020</year>
                  <pub-id pub-id-type="doi">10.1126/science.abd9338</pub-id>
                  <?supplied-pmid 33323424?>
                  <pub-id pub-id-type="pmid">33323424</pub-id>
                </element-citation>
              </ref>
              <ref id="CR2">
                <label>2.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Lai</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Ruktanonchai</surname>
                      <given-names>NW</given-names>
                    </name>
                    <name>
                      <surname>Zhou</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Prosper</surname>
                      <given-names>O</given-names>
                    </name>
                    <name>
                      <surname>Luo</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Floyd</surname>
                      <given-names>JR</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Effect of non-pharmaceutical interventions to contain COVID-19 in China</article-title>
                  <source>Nature</source>
                  <year>2020</year>
                  <volume>585</volume>
                  <issue>7825</issue>
                  <fpage>410</fpage>
                  <lpage>413</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41586-020-2293-x</pub-id>
                  <pub-id pub-id-type="pmid">32365354</pub-id>
                </element-citation>
              </ref>
              <ref id="CR3">
                <label>3.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Ruktanonchai</surname>
                      <given-names>NW</given-names>
                    </name>
                    <name>
                      <surname>Floyd</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Lai</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Ruktanonchai</surname>
                      <given-names>CW</given-names>
                    </name>
                    <name>
                      <surname>Sadilek</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Rente-Lourenco</surname>
                      <given-names>P</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Assessing the impact of coordinated COVID-19 exit strategies across Europe</article-title>
                  <source>Science</source>
                  <year>2020</year>
                  <volume>369</volume>
                  <issue>6510</issue>
                  <fpage>1465</fpage>
                  <lpage>1470</lpage>
                  <pub-id pub-id-type="doi">10.1126/science.abc5096</pub-id>
                  <pub-id pub-id-type="pmid">32680881</pub-id>
                </element-citation>
              </ref>
              <ref id="CR4">
                <label>4.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Chu</surname>
                      <given-names>DK</given-names>
                    </name>
                    <name>
                      <surname>Akl</surname>
                      <given-names>EA</given-names>
                    </name>
                    <name>
                      <surname>Duda</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Solo</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Yaacoub</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Schünemann</surname>
                      <given-names>HJ</given-names>
                    </name>
                  </person-group>
                  <article-title>Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis</article-title>
                  <source>Lancet</source>
                  <year>2020</year>
                  <volume>395</volume>
                  <issue>10242</issue>
                  <fpage>1973</fpage>
                  <lpage>1987</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0140-6736(20)31142-9</pub-id>
                  <pub-id pub-id-type="pmid">32497510</pub-id>
                </element-citation>
              </ref>
              <ref id="CR5">
                <label>5.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Fraser</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Riley</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Anderson</surname>
                      <given-names>RM</given-names>
                    </name>
                    <name>
                      <surname>Ferguson</surname>
                      <given-names>NM</given-names>
                    </name>
                  </person-group>
                  <article-title>Factors that make an infectious disease outbreak controllable</article-title>
                  <source>Proc Natl Acad Sci U S A</source>
                  <year>2004</year>
                  <volume>101</volume>
                  <issue>16</issue>
                  <fpage>6146</fpage>
                  <lpage>6151</lpage>
                  <pub-id pub-id-type="doi">10.1073/pnas.0307506101</pub-id>
                  <pub-id pub-id-type="pmid">15071187</pub-id>
                </element-citation>
              </ref>
              <ref id="CR6">
                <label>6.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Koo</surname>
                      <given-names>JR</given-names>
                    </name>
                    <name>
                      <surname>Cook</surname>
                      <given-names>AR</given-names>
                    </name>
                    <name>
                      <surname>Park</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Sun</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Sun</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Lim</surname>
                      <given-names>JT</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study</article-title>
                  <source>Lancet Infect Dis</source>
                  <year>2020</year>
                  <volume>20</volume>
                  <issue>6</issue>
                  <fpage>678</fpage>
                  <lpage>688</lpage>
                  <pub-id pub-id-type="doi">10.1016/S1473-3099(20)30162-6</pub-id>
                  <pub-id pub-id-type="pmid">32213332</pub-id>
                </element-citation>
              </ref>
              <ref id="CR7">
                <label>7.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Kretzschmar</surname>
                      <given-names>ME</given-names>
                    </name>
                    <name>
                      <surname>Rozhnova</surname>
                      <given-names>G</given-names>
                    </name>
                    <name>
                      <surname>Bootsma</surname>
                      <given-names>MCJ</given-names>
                    </name>
                    <name>
                      <surname>van Boven</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>van de Wijgert</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Bonten</surname>
                      <given-names>MJM</given-names>
                    </name>
                  </person-group>
                  <article-title>Impact of delays on effectiveness of contact tracing strategies for COVID-19: a modelling study</article-title>
                  <source>Lancet Public Health</source>
                  <year>2020</year>
                  <volume>5</volume>
                  <issue>8</issue>
                  <fpage>e452</fpage>
                  <lpage>e459</lpage>
                  <pub-id pub-id-type="doi">10.1016/S2468-2667(20)30157-2</pub-id>
                  <pub-id pub-id-type="pmid">32682487</pub-id>
                </element-citation>
              </ref>
              <ref id="CR8">
                <label>8.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Leung</surname>
                      <given-names>K</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>JT</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Leung</surname>
                      <given-names>GM</given-names>
                    </name>
                  </person-group>
                  <article-title>First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment</article-title>
                  <source>Lancet</source>
                  <year>2020</year>
                  <volume>395</volume>
                  <issue>10233</issue>
                  <fpage>1382</fpage>
                  <lpage>1393</lpage>
                  <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30746-7</pub-id>
                  <pub-id pub-id-type="pmid">32277878</pub-id>
                </element-citation>
              </ref>
              <ref id="CR9">
                <label>9.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Tian</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Liu</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>CH</given-names>
                    </name>
                    <name>
                      <surname>Chen</surname>
                      <given-names>B</given-names>
                    </name>
                    <name>
                      <surname>Kraemer</surname>
                      <given-names>MUG</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China</article-title>
                  <source>Science</source>
                  <year>2020</year>
                  <volume>368</volume>
                  <issue>6491</issue>
                  <fpage>638</fpage>
                  <lpage>642</lpage>
                  <pub-id pub-id-type="doi">10.1126/science.abb6105</pub-id>
                  <pub-id pub-id-type="pmid">32234804</pub-id>
                </element-citation>
              </ref>
              <ref id="CR10">
                <label>10.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Flaxman</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Mishra</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Gandy</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Unwin</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Juliette</surname>
                      <given-names>T</given-names>
                    </name>
                    <name>
                      <surname>Mellan</surname>
                      <given-names>TA</given-names>
                    </name>
                    <name>
                      <surname>Coupland</surname>
                      <given-names>H</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe</article-title>
                  <source>Nature</source>
                  <year>2020</year>
                  <volume>584</volume>
                  <issue>7820</issue>
                  <fpage>257</fpage>
                  <lpage>261</lpage>
                  <pub-id pub-id-type="doi">10.1038/s41586-020-2405-7</pub-id>
                  <pub-id pub-id-type="pmid">32512579</pub-id>
                </element-citation>
              </ref>
              <ref id="CR11">
                <label>11.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Wu</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>Q</given-names>
                    </name>
                    <name>
                      <surname>Zhao</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>P</given-names>
                    </name>
                    <name>
                      <surname>McGoogan</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Feng</surname>
                      <given-names>Z</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Time course of a second outbreak of COVID-19 in Beijing, China, June-July 2020</article-title>
                  <source>JAMA</source>
                  <year>2020</year>
                  <pub-id pub-id-type="doi">10.1001/jama.2020.15894</pub-id>
                  <?supplied-pmid 33170236?>
                  <pub-id pub-id-type="pmid">33170236</pub-id>
                </element-citation>
              </ref>
              <ref id="CR12">
                <label>12.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Pang</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Ren</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Ma</surname>
                      <given-names>W</given-names>
                    </name>
                    <name>
                      <surname>Yang</surname>
                      <given-names>J</given-names>
                    </name>
                    <name>
                      <surname>Di</surname>
                      <given-names>L</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Cold-chain food contamination as the possible origin of COVID-19 resurgence in Beijing</article-title>
                  <source>Natl Sci Rev</source>
                  <year>2020</year>
                  <volume>7</volume>
                  <issue>12</issue>
                  <fpage>1861</fpage>
                  <lpage>1864</lpage>
                  <pub-id pub-id-type="doi">10.1093/nsr/nwaa264</pub-id>
                </element-citation>
              </ref>
              <ref id="CR13">
                <label>13.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bennett</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Manuel</surname>
                      <given-names>DG</given-names>
                    </name>
                  </person-group>
                  <article-title>Reporting guidelines for modelling studies</article-title>
                  <source>BMC Med Res Methodol</source>
                  <year>2012</year>
                  <volume>12</volume>
                  <fpage>168</fpage>
                  <pub-id pub-id-type="doi">10.1186/1471-2288-12-168</pub-id>
                  <pub-id pub-id-type="pmid">23134698</pub-id>
                </element-citation>
              </ref>
              <ref id="CR14">
                <label>14.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Zhou</surname>
                      <given-names>L</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>Z</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>McGoogan</surname>
                      <given-names>JM</given-names>
                    </name>
                    <name>
                      <surname>Li</surname>
                      <given-names>Q</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>100 days of COVID-19 prevention and control in China</article-title>
                  <source>Clin Infect Dis</source>
                  <year>2020</year>
                  <pub-id pub-id-type="doi">10.1093/cid/ciaa725</pub-id>
                  <?supplied-pmid 33367582?>
                  <pub-id pub-id-type="pmid">33367582</pub-id>
                </element-citation>
              </ref>
              <ref id="CR15">
                <label>15.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Delignette-Muller</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Dutang</surname>
                      <given-names>C</given-names>
                    </name>
                  </person-group>
                  <article-title>Fitdistrplus: an R package for fitting distributions</article-title>
                  <source>J Stat Softw</source>
                  <year>2015</year>
                  <volume>64</volume>
                  <fpage>1</fpage>
                  <lpage>34</lpage>
                  <pub-id pub-id-type="doi">10.18637/jss.v064.i04</pub-id>
                </element-citation>
              </ref>
              <ref id="CR16">
                <label>16.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Haario</surname>
                      <given-names>H</given-names>
                    </name>
                    <name>
                      <surname>Saksman</surname>
                      <given-names>E</given-names>
                    </name>
                    <name>
                      <surname>Tamminen</surname>
                      <given-names>J</given-names>
                    </name>
                  </person-group>
                  <article-title>An adaptive metropolis algorithm</article-title>
                  <source>Bernoulli</source>
                  <year>2001</year>
                  <volume>7</volume>
                  <fpage>223</fpage>
                  <lpage>242</lpage>
                  <pub-id pub-id-type="doi">10.2307/3318737</pub-id>
                </element-citation>
              </ref>
              <ref id="CR17">
                <label>17.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Patil</surname>
                      <given-names>A</given-names>
                    </name>
                    <name>
                      <surname>Huard</surname>
                      <given-names>D</given-names>
                    </name>
                    <name>
                      <surname>Fonnesbeck</surname>
                      <given-names>CJ</given-names>
                    </name>
                  </person-group>
                  <article-title>PyMC: bayesian stochastic modelling in python</article-title>
                  <source>J. Stat. Softw.</source>
                  <year>2010</year>
                  <volume>35</volume>
                  <issue>4</issue>
                  <fpage>81</fpage>
                  <pub-id pub-id-type="doi">10.18637/jss.v035.i04</pub-id>
                </element-citation>
              </ref>
              <ref id="CR18">
                <label>18.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Cao</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Gan</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Wang</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Bachmann</surname>
                      <given-names>M</given-names>
                    </name>
                    <name>
                      <surname>Wei</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Gong</surname>
                      <given-names>J</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China</article-title>
                  <source>Nat Commun</source>
                  <year>2020</year>
                  <volume>11</volume>
                  <issue>1</issue>
                  <fpage>5917</fpage>
                  <pub-id pub-id-type="doi">10.1038/s41467-020-19802-w</pub-id>
                  <pub-id pub-id-type="pmid">33219229</pub-id>
                </element-citation>
              </ref>
              <ref id="CR19">
                <label>19.</label>
                <mixed-citation publication-type="other">Inocencio R. Coronavirus back in China: Entire city of Qingdao being tested after just 12 COVID-19 cases found. 2020. <ext-link ext-link-type="uri" xlink:href="https://www.cbsnews.com/news/coronavirus-china-qingdao-being-tested-12-covid-9-cases-found/">https://www.cbsnews.com/news/coronavirus-china-qingdao-being-tested-12-covid-9-cases-found/</ext-link>. Accessed 20 Dec 2020.</mixed-citation>
              </ref>
              <ref id="CR20">
                <label>20.</label>
                <element-citation publication-type="journal">
                  <person-group person-group-type="author">
                    <name>
                      <surname>Bi</surname>
                      <given-names>Q</given-names>
                    </name>
                    <name>
                      <surname>Wu</surname>
                      <given-names>Y</given-names>
                    </name>
                    <name>
                      <surname>Mei</surname>
                      <given-names>S</given-names>
                    </name>
                    <name>
                      <surname>Ye</surname>
                      <given-names>C</given-names>
                    </name>
                    <name>
                      <surname>Zou</surname>
                      <given-names>X</given-names>
                    </name>
                    <name>
                      <surname>Zhang</surname>
                      <given-names>Z</given-names>
                    </name>
                    <etal/>
                  </person-group>
                  <article-title>Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study</article-title>
                  <source>Lancet Infect Dis</source>
                  <year>2020</year>
                  <volume>20</volume>
                  <issue>8</issue>
                  <fpage>911</fpage>
                  <lpage>919</lpage>
                  <pub-id pub-id-type="doi">10.1016/S1473-3099(20)30287-5</pub-id>
                  <pub-id pub-id-type="pmid">32353347</pub-id>
                </element-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
